BA
XTNT icon

Bard Associates’s Xtant Medical Holdings XTNT Stock Holding History

Bard Associates’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,598
Closed -$89K – 180
2016
Q3 		$89K Sell
6,598
-4,033
-38% -$74.2K 0.04% 163
2016
Q2 		$244K Sell
10,631
-523
-5% -$13.5K 0.13% 134
2016
Q1 		$363K Sell
11,154
-242
-2% -$7.73K 0.21% 120
2015
Q4 		$383K Buy
+11,396
New +$400K 0.23% 111
2015
Q3 		– Sell
-12,963
Closed -$544K – 173
2015
Q2 		$544K Sell
12,963
-525
-4% -$26.7K 0.27% 99
2015
Q1 		$664K Sell
13,488
-191
-1% -$7.68K 0.32% 96
2014
Q4 		$497K Buy
13,679
+1,066
+8% +$44.3K 0.23% 115
2014
Q3 		$678K Buy
+12,613
New +$838K 0.32% 102

Other funds holding XTNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates's XTNT Position: Q4 2016 in Review

Bard Associates sold out of Xtant Medical Holdings (XTNT) in Q4 2016, closing a stake of 6,598 shares — an estimated $89K sold.

Bard Associates first reported a position in XTNT in Q3 2014 and held it in 8 quarters. The position peaked at $678K in Q3 2014. 22 funds tracked by Wall St. Rank hold XTNT as of Q4 2016.

  • Bard Associates reported no remaining Xtant Medical Holdings position as of Q4 2016 after selling out during the quarter.
  • Bard Associates sold 6,598 Xtant Medical Holdings shares in Q4 2016, an estimated $89K.
  • Bard Associates first reported a position in Xtant Medical Holdings in Q3 2014 and held it in 8 quarters.
  • Bard Associates's Xtant Medical Holdings position peaked at $678K in Q3 2014.
  • 22 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2016.

Based on Bard Associates's 13F filing for Q4 2016, filed 14 Feb 2017.